Novartis Farma S.p.A. Novartis Farmaceutica S.A. Novartis Farma-Productos Farmaceuticos S.A. Novartis Finland Oy Novartis (Hellas) S.A.C.I. Novartis Hungaria Kft. Novartis Pharma B.V. Novartis Pharma GmbH Novartis Pharma GmbH Novartis Pharma nv Novartis Pharma S.A.S Novartis Poland Sp. z o.o. Novartis s.r.o. Novartis Sverige AG
PolandAll drugs from this manufacturer
-
The medicine is used to treat high blood pressure (hypertension) that cannot be controlled using single ingredients administered separately.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DA03
-
The medicine is used to treat acromegaly (excess growth hormone), to relieve symptoms of gastrointestinal tumors, to prevent complications after pancreatic surgery, to inhibit bleeding from gastroesophageal varices, and to treat TSH-secreting pituitary tumors.
Dosage form: solution for injection for infusion
Active substance Dosage octreotide acetate 0.05 mg ATC: H01CB02
-
The medicine is used to treat acromegaly (excess growth hormone), to relieve symptoms of gastrointestinal tumors, to prevent complications after pancreatic surgery, to inhibit bleeding from gastroesophageal varices in patients with liver cirrhosis, and to treat TSH-secreting pituitary tumors.
Dosage form: solution for injection for infusion
Active substance Dosage octreotide acetate 100 mcg/ml ATC: H01CB02